Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effects of the dihydropyridine calcium channel antagonists, nifedipine and nimodipine (300 n m‐30 μ m) were tested in vitro on intracellularly recorded dopaminergic neurones in the rat ventral mesencephalon. Bath applied nifedipine and nimodipine inhibited in a concentration‐dependent manner the spontaneous firing discharge of the action potentials, whereas, the dihydropyridine calcium channel agonist, Bay K 8644 increased the firing rate. Pacemaker oscillations and bursts of action potentials were produced by loading the cells with caesium. Nifedipine and nimodipine reduced the rate and the duration of the caesium‐induced membrane oscillations and decreased the number of action potentials in a burst. During the blockade of potassium currents the dopaminergic neurones often developed a prolonged (100–800 ms) afterdepolarization that was also inhibited by dihydropyridines. The spontaneous discharge of calcium spikes was also inhibited by both dihydropyridine calcium antagonists. The apparent input resistance and the level of membrane potential were not affected by the dihydropyridine calcium antagonists. If the action potential duration was less than 150 ms the shape of the spike was not clearly influenced by both calcium antagonists. However, when the duration of the action potential was longer than 150–200 ms due to the intracellular injection of caesium ions plus the extracellular application of tetraethylammonium (10–50 μ m), both nifedipine and nimodipine reversibly shortened the plateau potential. It is suggested that nifedipine and nimodipine depress the rhythmic and bursting activity of the dopaminergic cells and shorten the calcium action potential by blocking dihydropyridine‐sensitive high‐threshold calcium currents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Llinás, R. R. (1988) · Science · doi:10.1126/science.3059497 · Cited by 2,285
Cited by
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904
MPTP Mouse Models of Parkinson's Disease: An Update
Meredith, G. E., & Rademacher, D. J. (2011) · Journal of Parkinson’s Disease · doi:10.3233/jpd-2011-11023 · Cited by 514
Burst firing in midbrain dopaminergic neurons
Overton, P. G., & Clark, D. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00039-8 · Cited by 466
Robust Pacemaking in Substantia Nigra Dopaminergic Neurons
Guzman, J. N., Sánchez-Padilla, J., Chan, C. S., & Surmeier, D. J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2519-09.2009 · Cited by 411
Metadata
- Authors
- Mercuri, N. B., Bond, A., Calabresi, P., Stratta, F., Stefani, A., & Bernardi, G.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1994-11
- Volume
- 113
- Issue
- 3
- Pages
- 831-838
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2005452816
- Cited by
- 143
- References
- 1
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones. https://app.cochat.ai/papers/10.1111/j.1476-5381.1994.tb17068.x
- The paper
- Mercuri, N. B., Bond, A., Calabresi, P., Stratta, F., Stefani, A., & Bernardi, G. (1994). Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1994.tb17068.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.